Clinical Trials Browser

NETWORK × Lung Neoplasms × Sorafenib × Clear all

NCT00064350 2023-06-29

Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer

Phase 2 Completed

342 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms